Business Context and Reporting Period
This Form 6-K was filed by GlaxoSmithKline plc and GlaxoSmithKline Capital plc on March 25, 2019. The registrants are foreign private issuers based in Brentford, Middlesex, United Kingdom. The filing serves to incorporate legal opinions by reference into a Registration Statement on Form F-3 (File Nos. 333-223982 and 333-223982-02).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics. This document is a procedural filing regarding legal opinions and registration statements rather than a financial results report.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No financial or operational comparisons are included in this specific document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses on the incorporation of legal opinions from Cleary Gottlieb Steen & Hamilton LLP (U.S. and English counsel) into the registrants' shelf registration statement.
Key Facts for Investor Verification
- The filing incorporates legal opinions (Exhibits 5.1 and 5.2) into Form F-3 registration statements.
- The registrants are GlaxoSmithKline plc and GlaxoSmithKline Capital plc.
- The filing date is March 25, 2019.
- No financial performance data is contained within this specific Form 6-K.